EconoTimes1 天
FDA Approves Ozempic for Kidney and Heart Protection in Diabetic Patients
The U.S. Food and Drug Administration (FDA) has approved Novo Nordisks (NYSE:NVO) Ozempic for reducing the risk of kidney ...
Medical News Today1 天
Calorie restriction plus common diabetes drug leads to higher remission rates
A combination of an SGLT-2 inhibitor drug and a moderately calorie-restrictive diet leads to higher rates of type 2 diabetes ...
FDA OK's Ozempic to protect kidneys in type 2 diabetes patients
A popular diabetes drug just got a major new approval—and it could be a game-changer for millions of Americans at risk for ...
FDA approves Ozempic for diabetes patients to cut kidney disease risk
The FDA approval is based on results from a trial investigating the effects of once-a-week Ozempic injections on major kidney ...
US FDA approves Novo Nordisk's Ozempic to reduce risk of kidney diseases in diabetic patients
Breakthrough in diabetes treatment! The US FDA approves Ozempic for reducing kidney disease risk in diabetic patients. Learn ...
FDA approves Novo Nordisk's diabetes drug Ozempic for chronic kidney disease, expanding use ...
Ozempic’s expanded approval in the U.S. could transform how doctors treat patients with the condition, which involves a ...
ITV26 天
Doctor 'cures' more than 100 type 2 diabetes patients with 'diet not drugs' approach
Patients are five times more likely to develop heart disease or have a stroke. Actor Sally Bankes said she lost three stone since starting her diet for her type 2 diabetes. Credit: ITV News ...
US FDA approves Novo Nordisk's Ozempic to cut risk of diabetic kidney disease progression
The U.S. FDA has approved Novo Nordisk's Ozempic for reducing the risk of kidney failure and disease progression, as well as ...